Skip to main content

D1 – Clinical Orientation & Value Governance

Purpose of the Domain

D1 ensures that digital clinical infrastructure is consistently aligned with clinical effectiveness.

Digital systems must not be introduced primarily based on technical feasibility, vendor dynamics, or budget logic.
Their legitimacy derives solely from their structural contribution to patient care.

This domain operationalizes Principle P1 – Clinical Effectiveness – at the organizational level.

Core Governance Question

Is digital infrastructure systematically prioritized, evaluated, and governed along clearly defined clinical objectives?

D1 does not focus on individual projects.
It addresses the structural decision architecture of the organization.

Problem Context

In many organizations, digital investments are driven by:

  • innovation pressure
  • project dynamics
  • technical attractiveness
  • funding opportunities
  • isolated departmental demands

Without structured value governance, the result is often:

  • fragmented system landscapes
  • increasing complexity without clinical benefit
  • inconsistent prioritization
  • long-term resource allocation without measurable impact

Clinical effectiveness may be rhetorically emphasized,
but not structurally embedded as a binding decision criterion.

Structural Requirements

A mature expression of D1 requires:

  • Clearly defined clinical target states
  • Binding benefit criteria prior to investment decisions
  • Documented benefit assumptions
  • Prioritization aligned with clinical impact
  • Structured post-implementation evaluation
  • Willingness to discontinue systems without demonstrable value

Clinical purpose responsibility must be institutionally anchored —
not merely project-based or dependent on individuals.

Relationship to Other Domains

  • D1 defines why digital infrastructure is introduced.
  • D2 defines how it is systemically embedded.
  • D3 clarifies who holds responsibility.
  • D4 assesses which risks emerge.
  • D5 ensures long-term structural sustainability.
  • D6 governs controlled evolution and innovation.

D1 is therefore the normative entry domain —
but not an isolated authority structure.

Typical Misconceptions

  • “If it works technically, it must be beneficial.”
  • “Efficiency gains automatically improve care quality.”
  • “Departmental demand alone justifies implementation.”
  • “Innovation itself legitimizes introduction.”

Clinical effectiveness is not a by-product of good technology.
It is a leadership decision.

Indicators of Structural Stability

D1 is structurally stable when:

  • Prioritization transparently follows clinical impact
  • Benefit arguments are documented and traceable
  • Clinical goal conflicts are openly discussed
  • Resources are allocated according to care relevance

D1 is weakly developed when:

  • Technical opportunity dominates decision-making
  • Projects are initiated in isolation
  • Benefit assumptions remain unverified
  • Investments evolve historically rather than strategically

D1 establishes the structural foundation
for ensuring that digital infrastructure serves clinical care —
and not the other way around.